Literature DB >> 23691487

A new method of establishing orthotopic bladder transplantable tumor in mice.

Xi-Hua Yang1, Lian-Sheng Ren, Guo-Ping Wang, Li-Li Zhao, Hong Zhang, Zhen-Guo Mi, Xihua Bai.   

Abstract

OBJECTIVE: The present study aims to find a convenient, rapid, and stable method to establish bladder tumor in mice.
METHODS: Female Balb/C-nu-nu nude mice (or female T739 mice) were narcotized by sodium pentobarbital at a dosage of 60 mg/kg. The stylet of the 24# venous retention needles was bent in a 5° to 7° angle at a distance of 15 mm from the needlepoint to form a circle with 2.61 mm to 3.66 mm radius when the stylet is rotated. The pipe casing was lubricated with liquid paraffin, and inserted into the bladder cavity. The drift angle stylet was inserted into the pipe casing slowly, rotated for five times, and then pulled out. A cell suspension (0.1 mL) of approximately 1×10(6) T24 cells (or BTT cells) was then injected immediately.
RESULTS: A total of 60 T739 mice and 60 Balb/C-nu-nu nude mice were inoculated with BTT cells and T24 cells, respectively. The bladder tumor incidence and the average survival time of the tumor-bearing mice were 100% and (26.69±9.24) d and 100% and (34.59±9.8) d for the T739 mice and Balb/C-nu-nu nude mice, respectively.
CONCLUSIONS: Using the drift angle stylet to injure the mucous membrane of the urinary bladder can establish a stable bladder transplantable tumor model in mice.

Entities:  

Keywords:  bladder tumor; mice; model

Year:  2012        PMID: 23691487      PMCID: PMC3643680          DOI: 10.7497/j.issn.2095-3941.2012.04.007

Source DB:  PubMed          Journal:  Cancer Biol Med        ISSN: 2095-3941            Impact factor:   4.248


Introduction

Bladder cancer is one of the most common malignant tumors. Most cases progress to high-grade invasive cancer despite long-standing intravesical therapies. Novel therapeutic treatment options are urgently needed to improve the overall treatment success rates for localized bladder cancer[]. Therefore, stable, reliable, simple, and reproducible orthotopic animal models are critically important. Suitable animal models provide an opportunity to study the mechanism of pathogenesis and allow the research and development of novel therapeutic agents. In this study, we have successfully established a model of orthotopic bladder tumor in mice using a drift angle stylet to injure the mucous membrane of the urinary bladder. The tumor cells grew on the wall of the urinary bladder after tumor cell injection. This method is convenient, rapid, and stable for establishing bladder tumor in mice and demonstrates the growth, infiltration, and metastasis of the tumor.

Materials and Methods

Preparation of the drift angle stylet

The stylet of the 24# venous retention needles (Becton Dickinson Infusion Therapy Systems, Inc., America) was bent in a 5° to 7° angle at a distance of 15 mm from the needlepoint to form a Φ=2.61 mm to 3.66 mm circle when the stylet was rotated ().
Figure 1

Schematic diagram of the pipe casing (A) and the drift angle stylet (B).

Schematic diagram of the pipe casing (A) and the drift angle stylet (B).

Cell strain

Mice urinary bladder transitional cancer cell line BTT-T739, which originated from inbred line T739 mice, is a carcinogen-induced [N-butyl-N-(4-hydroxybutyl) nitrosamine] poorly differentiated transitional carcinoma. The cell line was provided by Professor Yang Xiaofeng from Shanxi Medical University. Human urinary bladder T24 cell strain was purchased from Shanghai Institutes for Biological Science, CAS. The cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37°C and 5% CO2. The cells were harvested by trypsin/EDTA treatment. Viability was determined using the trypan blue exclusion method. The cells were suspended in prepared PBS at a concentration of 1×107/mL.

Animal

The present study was approved by the local ethics committee and followed the guidelines of the National Research Council Guide for the Care and Use of Laboratory Animals. Female inbred line T739 mice, 4 weeks to 6 weeks old and weighing 20 g to 22 g, were purchased from Beijing HFK Bio-Technology Co. Ltd. The animal produce license number was SCXK (Jing) 2009-0004. Female Balb/C-nu-nu mice, 4 weeks to 6 weeks old and weighing 20 g to 22 g, were purchased from Vital River Laboratories. The animal produce license number was SCXK (Jing) 2006-0009. The animals were bred in the animal laboratory (license number of SYXK (Jin) 2007-0002). The temperature and humidity of the environment was kept at (26±1.5)°C and between 40% and 60%, respectively. The mice were provided with sterilized drinking water and sterile complete nutrition feed.

The orthotopic transplantation of the tumor cell

The mice in the experimental group were narcotized by sodium pentobarbital at a dosage of 60 mg/kg. The pipe casing was lubricated with liquid paraffin and inserted into the bladder cavity, and then urine was removed. The drift angle stylet was slowly inserted into the pipe casing. The pipe casing was fixed with one hand, the stylet was rotated for five rounds with the other hand, and then pulled out. Cell suspension (100 µL) of approximately 1×106 cells was injected immediately. The mice in the normal control group were injected with 1×106 cells directly without mucosa injury. The comparison results between the mucosa injured and uninjured urinary bladder are shown in .
Figure 2

Comparison between the mucosa injured and mucosa uninjured urinary bladder. A: mucosa uninjured; B: mucosa injured. The bladders were injected with physiological saline.

Comparison between the mucosa injured and mucosa uninjured urinary bladder. A: mucosa uninjured; B: mucosa injured. The bladders were injected with physiological saline.

Observation method

The tumor cell-inoculated mice were fed routinely. The activity and body weight of the mice were observed daily, and survival time was recorded. All mice that died of natural causes were dissected and checked for tumor formation on the urinary bladder and abdominal cavity and hematuria. Metastasis and wet weight of the urinary bladder were recorded after the dissection. The urinary bladder and tumor metastasized organs were fixed in 10% formaldehyde for pathological examination. The observation time of the T739 mice was 40 d, whereas that of the Balb/C-nu-nu mice was 60 d.

Results

Tumor development

A total of 60 T739 mice were inoculated with BTT cells in the experimental group. The results showed that the bladder tumor incidence was 100% and the average wet weight of the tumor was (0.54±0.37) g. Ten T739 mice were inoculated with BTT cells in the mucosa uninjured control group; the bladder tumor incidence was 0% (, ).
Table 1

Comparison of tumor incidence between the mucosa uninjured bladder and mucosa injured bladder by drift angle stylet.

GroupsNumber of miceCell inoculation amountTumor developed amountTumor incidence (%)
T739 without injury101×10600
T739 with injury601×10660100
Balb/C-nu-nu without injury101×10600
Balb/C-nu-nu with injury601×10660100
Figure 3

Comparison between the early-stage tumor and advanced-stage tumor on the urinary bladder. A: tumor formation in the early stage; B: tumor formation in the advanced stage.

Comparison between the early-stage tumor and advanced-stage tumor on the urinary bladder. A: tumor formation in the early stage; B: tumor formation in the advanced stage. A total of 60 Balb/C-nu-nu nude mice were inoculated with T24 cells in the experimental group. The results showed that the bladder tumor incidence was 100% and the average wet weight was (0.11±0.13) g. The bladder tumor incidence in the normal control group was 0% (, ).

Metastasis

Metastases in the liver, kidney, mesentery, and peritoneum with bloody ascites were observed in 23% of the 60 T739 mice inoculated with BTT cells. Abdominal cavity adhesion was observed, and metastasis occurred either on several viscera (liver, kidney, mesentery, and peritoneum) or only one viscera (kidney) (). Only one of the 60 Balb/C-nu-nu mice inoculated with T24 cells had metastasis in the kidney ().
Figure 4

Metastasis in the liver (A) and the kidney (B).

Metastasis in the liver (A) and the kidney (B).

Survival time

T739 mice in the experimental group began to die on the 16th day after BTT cell inoculation. The animals had serious athrepsia with hematuria. The average survival time of the mice was (26.69±9.24) d. In addition, a number of mice died from extreme athrepsia and cachexia (). Balb/C-nu-nu mice in the experimental group began to die on the 18th day after T24 cell inoculation. The average survival time of the mice was (34.59±9.8) d. The mice had extreme athrepsia and cachexia (, ).
Table 2

Average survival time and bladder weight of the mice transplanted with tumor cells.

GroupsNumber of miceAverage survival time (days)Average tumor wet weight
T739 without injury10>400.02±0.22
T739 with injury6026.69±9.240.54±0.37
Balb/C-nu-nu without injury10>600.02±0.32
Balb/C-nu-nu with injury6034.59±9.800.11±0.13
Figure 5

Survival time function of the T739 mice (A) and Balb/C-nu-nu nude mice (B).

Survival time function of the T739 mice (A) and Balb/C-nu-nu nude mice (B).

Pathological examination

The bladder mucosa of the normal control mice was intact, and no metastasis was observed (). Huge solid tumors were observed under the microscope. The tumor cells infiltrated deeply into the muscular layer (). Cellular atypia was observed in the pathological section of the liver and kidney ( and ).
Figure 6

Pathological images of different groups. A: The normal control group bladder (H&E staining, ×100); B: The model group bladder with tumor (H&E staining, ×100); C: The metastasis in liver (H&E staining, ×200); D: The metastasis in kidney (H&E staining, ×200).

Pathological images of different groups. A: The normal control group bladder (H&E staining, ×100); B: The model group bladder with tumor (H&E staining, ×100); C: The metastasis in liver (H&E staining, ×200); D: The metastasis in kidney (H&E staining, ×200).

Discussion

Orthotopic bladder transplantable tumor in mice is a practical model because it is analogous to the clinical pathological process in humans[]. Four frequently used methods are classified by their difference in inoculation process, and are described as follows. The first method is intravesical instillation of tumor cell suspension[] into denuded bladders, which uses N-methyl-N-nitrosourea[] or combination of chlorhydric acid and potassium hydroxide[,]. This method requires no surgery and does not result in diffuse ulceration, edema, or urinary stones. The success rate of tumor implantation ranges from 28% to 97%. Moreover, the tumors appear multifocal and have an unpredictable localization. The second method is injecting tumor cells into the urinary bladder wall through the abdomen[-]. This method requires a skilled surgeon to complete the surgery and is time consuming. The third method is injecting weak acid, protease, or other chemicals into the urinary bladder entocoel to injure the mucous before the injection of tumor cells[,-]. This method is also complicated and tumor formation was not stable. The fourth method is the mechanical method. The mucous membrane of the urinary bladder was injured before the injection of tumor cells[]. Bisson et al.[] inserted a stylet with an outside casing into the urinary bladder through the meatus urinarius to injure the mucous. The method does not have any restrictions to the rotation degree of the stylet; thus the degree of injury to the mucous cannot be controlled. Creating an injury in the mucous of the urinary bladder is important in tumor transplantation. Hemorrhage and damage to the mucous after the injury are beneficial to the adhesion, colonization, and growth of tumor cells. An intact mucosa protects the bladder from tumor cell invasion. The drift angle stylet forms a Φ=2.61 mm to 3.66 mm circle when rotated, causing a balanced injury. Thus, the injury is controllable, and the method is more reasonable. Bisson et al.[] used a custom-made copper abrader to establish a bladder tumor. The result showed that the tumor incidence was approximately 100%. Using a mechanical damage method to induce an injury to the bladder mucosa was feasible to establish an orthotopic bladder tumor. Spotted state injury was induced by friction when rotated. Tiny tumors developed at an early stage and progressed slowly. The drift angle stylet can augment the wound surface when rotated. A number of tumor cells colonized on the mucous at an early stage, and tumors formed within a short period of time. The present model showed a high metastatic rate. Vesicoureteral reflux may cause renal metastasis. Metastasis may also have a relationship with the cell line because the metastatic rate of T24 was lower than that of BTT. Tumors that has broken through the bladder wall and invaded into the abdominal cavity are in the advanced stage, leading to high metastatic rate. The 24# venous retention needle used in the present study is a standard medical device and is easy to obtain. The preparation of the drift angle stylet is simple, and the experiment is easy to perform. Moreover, the degree of injury is easy to control. Using drift angle stylet to injure the mucous membrane of the urinary bladder can establish a stable transplantable bladder tumor model in mice, with convenience and rapidness.
  14 in total

1.  A model of orthotopic murine bladder (MBT-2) tumor implants.

Authors:  F Jiang; X M Zhou
Journal:  Urol Res       Date:  1997

2.  Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants.

Authors:  J Chin; S Kadhim; B Garcia; Y S Kim; S Karlik
Journal:  J Urol       Date:  1991-06       Impact factor: 7.450

3.  Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model.

Authors:  R Bachor; T J Flotte; M Scholz; S Dretler; T Hasan
Journal:  J Urol       Date:  1992-05       Impact factor: 7.450

Review 4.  Mouse orthotopic models for bladder cancer research.

Authors:  Eddie Chan; Amit Patel; Warren Heston; William Larchian
Journal:  BJU Int       Date:  2009-04-16       Impact factor: 5.588

5.  Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study.

Authors:  E H Ibrahiem; V N Nigam; C A Brailovsky; P Madarnas; M Elhilali
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

6.  Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography.

Authors:  J V Harney; R L Wahl; M Liebert; D E Kuhl; G D Hutchins; G Wedemeyer; H B Grossman
Journal:  J Urol       Date:  1991-02       Impact factor: 7.450

7.  Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice.

Authors:  C P Dinney; R Fishbeck; R K Singh; B Eve; S Pathak; N Brown; B Xie; D Fan; C D Bucana; I J Fidler
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

8.  A model of bladder tumor xenografts in the nude rat.

Authors:  G S Oshinsky; Y Chen; T Jarrett; A E Anderson; G H Weiss
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

9.  Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.

Authors:  Z Xiao; T J McCallum; K M Brown; G G Miller; S B Halls; I Parney; R B Moore
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

10.  Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model.

Authors:  Daher C Chade; Ricardo C Borra; Ivan P Nascimento; Fabiola E Villanova; Luciana C C Leite; Enrico Andrade; Miguel Srougi; Kátia L Ramos; Priscila M Andrade
Journal:  J Exp Clin Cancer Res       Date:  2008-11-28
View more
  13 in total

1.  Evaluation of Su Fu'ning Lotion's Inhibitory Effects on Bladder Cancer Cells In Vitro and In Vivo by Intravesical Instillation.

Authors:  Liansheng Ren; Xihua Yang; Lili Zhao; Hong Zhang; Jing Wang
Journal:  Integr Cancer Ther       Date:  2015-08-27       Impact factor: 3.279

2.  Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Authors:  Peter A Raven; Ninadh M D'Costa; Igor Moskalev; Zheng Tan; Sebastian Frees; Claudia Chavez-Munoz; Alan I So
Journal:  Am J Clin Exp Urol       Date:  2018-12-20

3.  Synovial fibroblast-derived exosomal microRNA-106b suppresses chondrocyte proliferation and migration in rheumatoid arthritis via down-regulation of PDK4.

Authors:  Dan Liu; Yuxuan Fang; Yujun Rao; Wei Tan; Wei Zhou; Xia Wu; Chunwang Zhang; Yu Zhang; Yanqing Liu; Masataka Sunagawa; Tadashi Hisamitsu; Guoqing Li
Journal:  J Mol Med (Berl)       Date:  2020-02-20       Impact factor: 4.599

4.  Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer.

Authors:  Tzu-Yin Lin; Yuanpei Li; Qiangqiang Liu; Jui-Lin Chen; Hongyong Zhang; Diana Lac; Hua Zhang; Katherine W Ferrara; Sebastian Wachsmann-Hogiu; Tianhong Li; Susan Airhart; Ralph deVere White; Kit S Lam; Chong-Xian Pan
Journal:  Biomaterials       Date:  2016-07-22       Impact factor: 12.479

5.  Animal models for bladder cancer: The model establishment and evaluation (Review).

Authors:  Ning Zhang; Dongyang Li; Jialiang Shao; Xiang Wang
Journal:  Oncol Lett       Date:  2015-01-23       Impact factor: 2.967

6.  P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.

Authors:  Byung Hoon Chi; Soon-Ja Kim; Ho Kyung Seo; Hye-Hyun Seo; Sang-Jin Lee; Jong Kyou Kwon; Tae-Jin Lee; In Ho Chang
Journal:  J Korean Med Sci       Date:  2015-02-16       Impact factor: 2.153

7.  A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model.

Authors:  Chantal Scheepbouwer; Sandra Meyer; Maroeska J Burggraaf; Jithin Jose; Carla F M Molthoff
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

8.  An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment.

Authors:  Doreen Huebner; Christiane Rieger; Ralf Bergmann; Martin Ullrich; Sebastian Meister; Marieta Toma; Ralf Wiedemuth; Achim Temme; Vladimir Novotny; Manfred P Wirth; Michael Bachmann; Jens Pietzsch; Susanne Fuessel
Journal:  BMC Cancer       Date:  2017-11-23       Impact factor: 4.430

Review 9.  Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.

Authors:  Bincy Anu John; Neveen Said
Journal:  Oncotarget       Date:  2017-05-09

10.  The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model.

Authors:  Xiaoping Yang; Lih-Jen Su; Francisco G La Rosa; Elizabeth Erin Smith; Isabel R Schlaepfer; Suehyun K Cho; Brian Kavanagh; Wounjhang Park; Thomas W Flaig
Journal:  Bladder Cancer       Date:  2017-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.